Originally published on the Biosimilars Council.
Biosimilar medicines are revolutionary therapeutics that treat patients at a fraction of the cost of brand-name biologics. However, public awareness and trust of biosimilars is still evolving, meaning many patients and providers are overpaying for expensive brand-name biologics. To address this education gap, the Biosimilars Council launched a new, one-of-a-kind educational resource: the Biosimilars Patient Resource Center.
The Biosimilars Patient Resource Center is a convenient site for answers to your pressing questions about biosimilar medicines. Whether you are a current or potential biosimilar or biologics patient, a caregiver, a medical professional, a policymaker, or if you just want to know more about biosimilars, the Biosimilars Patient Resource Center has information you can use.
As you browse through our new website, you will find a collection of up-to-date resources.
On the frequently asked questions page, you will find answers to common questions about biosimilars, from the most fundamental (what is a biosimilar?) to the more detailed (what does interchangeability mean?).
The stories page, includes stories from real patients who are living healthy, happy lives thanks to affordable biosimilars medicines. For example, Eileen, a 28-year-old musical theatre enthusiast in New York City, switched to a biosimilar after she lost insurance coverage for her biologic treatment for Crohn’s Disease.
We encourage you to check out the Biosimilars Patient Resource Center and other resources that can be found on our website. For more information about how you can join the biosimilars movement and advocate for greater access, visit our advocacy page.
By Erica Klinger, Senior Director, Marketing
Published on May 31, 2022